Drug interactions
Empagliflozin-metformin + Insulin aspart
Severity: Moderate
Empagliflozin-metformin and Insulin aspart: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Empagliflozin and metformin both lower glucose and add to the effect of insulin, increasing the risk of hypoglycemia. This is an expected combination in type 2 diabetes but usually requires insulin dose reduction.
What this interaction means in plain words
Empagliflozin-metformin and Insulin aspart can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Empagliflozin-metformin belongs to Endocrine; Insulin aspart belongs to Endocrine.
Why it happens
Additive glucose-lowering through different mechanisms, with insulin-independent glucosuria and reduced hepatic glucose output.
What to do
Monitor glucose closely when starting the combination and consider lowering the insulin dose. Educate patients on recognizing hypoglycemia.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-metformin and Insulin aspart, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Empagliflozin-metformin
Other interactions of Insulin aspart
Frequently asked questions
Can I take Empagliflozin-metformin with Insulin aspart?
MediHelp rates the interaction as moderate. Empagliflozin-metformin and Insulin aspart can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Empagliflozin and metformin both lower glucose and add to the effect of insulin, increasing the risk of hypoglycemia. This is an expected combination in type 2 diabetes but usually requires insulin dose reduction.
How serious is the interaction between Empagliflozin-metformin and Insulin aspart?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose closely when starting the combination and consider lowering the insulin dose. Educate patients on recognizing hypoglycemia.
What other medicines interact with Empagliflozin-metformin?
MediHelp also lists interactions of Empagliflozin-metformin with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Empagliflozin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
